Patients were selected for inclusion in this study from different cohorts tested on either family-based WES, targeted resequencing or high-resolution melting analysis (Table 1). Clinical evaluation was performed by at least one expert clinical geneticist. Written informed consent for inclusion in the study was obtained for all patients and consent for the publication of photographs was obtained for patients 1, 2, 4, 5, 6 and 8.
